| Autor: |
Abd Allah, Marwa Abdul Rahim, Elfattah Afify, Ahmed Abd, ElSayed ElSawy, Hana Mohammed |
| Zdroj: |
QJM: An International Journal of Medicine; 2024 Supplement, Vol. 117, pii88-ii88, 1p |
| Abstrakt: |
Acral vitiligo is a resistant subtype of vitiligo that does not respond easily to any treatment modalities. Topical psoralen plus ultraviolet A (topical PUVA) therapy is an option in case of localized dermatosis such as acral vitiligo. Ultraviolet A therapy can penetrate the dermis of the skin. This study objective was to evaluate the effect of topical PUVA in acral vitiligo. Methods: Patients in this prospective randomized-controlled comparative clinical trial were divided in to two groups, first group received narrow band ultraviolet B (NB-UVB) and topical PUVA at the same time, second group were already on NB-UVB and topical PUVA were added. Patients received 36 sessions of phototherapy over a period of 16 weeks. Every patient was evaluated monthly using point counting. Results: No statistically significant difference was found between both groups regarding response. Conclusion: Topical PUVA is of limited use in acral vitiligo. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
